| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.03 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.03 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.03 |